600080 Stock Overview
Ginwa Enterprise (Group) Inc. investiga, desarrolla, produce y vende productos farmacéuticos en China.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Ginwa Enterprise (Group) Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.10 |
| 52 Week High | CN¥8.10 |
| 52 Week Low | CN¥4.53 |
| Beta | 0.23 |
| 1 Month Change | -0.70% |
| 3 Month Change | -7.55% |
| 1 Year Change | -10.13% |
| 3 Year Change | 17.36% |
| 5 Year Change | -17.63% |
| Change since IPO | -37.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600080 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.2% | 0.7% | 0.9% |
| 1Y | -10.1% | -14.7% | -16.5% |
Rentabilidad frente al sector: 600080 superó al sector CN Pharmaceuticals , que obtuvo un rendimiento del -12.3% el año pasado.
Rentabilidad vs. Mercado: 600080 superó al mercado CN, que obtuvo un rendimiento del -15.4% el año pasado.
Price Volatility
| 600080 volatility | |
|---|---|
| 600080 Average Weekly Movement | 8.6% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 11.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Precio estable de las acciones: 600080ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 600080 (8%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 600 | n/a | https://www.ginwa.com.cn |
Ginwa Enterprise (Group) Inc. investiga, desarrolla, produce y vende productos farmacéuticos en China. La empresa ofrece productos ortopédicos, inmunitarios, pediátricos, antibióticos, para el aparato digestivo, ginecológicos, cardiovasculares, antipiréticos, analgésicos y antivirales, entre otros. Ofrece sus productos en forma de comprimidos, cápsulas, gránulos, polvos, mezclas, soluciones orales, jarabes y soluciones externas.
Ginwa Enterprise (Group) Inc. Fundamentals Summary
| 600080 fundamental statistics | |
|---|---|
| Market cap | CN¥2.65b |
| Earnings (TTM) | CN¥5.02m |
| Revenue (TTM) | CN¥559.03m |
527.9x
P/E Ratio4.7x
P/S RatioIs 600080 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600080 income statement (TTM) | |
|---|---|
| Revenue | CN¥559.03m |
| Cost of Revenue | CN¥131.58m |
| Gross Profit | CN¥427.45m |
| Other Expenses | CN¥422.43m |
| Earnings | CN¥5.02m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 27, 2024
| Earnings per share (EPS) | 0.013 |
| Gross Margin | 76.46% |
| Net Profit Margin | 0.90% |
| Debt/Equity Ratio | 4.5% |
How did 600080 perform over the long term?
See historical performance and comparison